135908-33-7 Usage
General Description
4-AMINOBICYCLO[2.2.2]OCTANE-1-CARBOXYLIC ACID METHYL ESTER is a chemical compound with the molecular formula C10H17NO2. It is a methyl ester derivative of the amino acid 4-aminobicyclo[2.2.2]octane-1-carboxylic acid. 4-AMINOBICYCLO[2.2.2]OCTANE-1-CARBOXYLIC ACID METHYL ESTER is not commonly found in nature, but it is used in the pharmaceutical industry as a building block for the synthesis of various drugs and biologically active compounds. It has been studied for its potential as a drug delivery system due to its unique bicyclic structure and potential interactions with biological systems. Additionally, it may also have applications in organic synthesis and medicinal chemistry as a versatile intermediate for the production of diverse molecular structures.
Check Digit Verification of cas no
The CAS Registry Mumber 135908-33-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,9,0 and 8 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 135908-33:
(8*1)+(7*3)+(6*5)+(5*9)+(4*0)+(3*8)+(2*3)+(1*3)=137
137 % 10 = 7
So 135908-33-7 is a valid CAS Registry Number.
135908-33-7Relevant articles and documents
2,3-DIHYDRO-1H-PYRROLIZINE-7-FORMAMIDE DERIVATIVE AND APPLICATION THEREOF
-
, (2021/04/16)
The present application relates to a 2,3-dihydro-1H-pyrrolizine-7-formamide derivative as a nucleoprotein inhibitor and a use in preparation of a drug for treating HBV related diseases. The present application specifically relates to a compound represented by formula (II), and isomers or pharmaceutically acceptable salts thereof.
GUT MICROSOMAL TRIGLYCERIDE TRANSPORT PROTEIN INHIBITORS
-
Page/Page column 123, (2008/12/08)
Compounds represented by formula (I): are inhibitors of gut microsomal triglyceride transfer protein. Such compounds are useful in treating diseases or conditions such as diabetes and obesity, along with patients are risk for developing such diseases or conditions.
